Skip to main content
OpenTrials
Completed

NCT Number: NCT03132688

A Study on Safety and Efficacy of Propofol in Small Children Under 2 Years of Age

This retrospective study the safety and efficacy of intravenous propofol used in children under 2 years of age during general anesthesia for surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 2 year

Sex eligibility

All sexes

Study type

Observational

Primary location

SNUH

Seoul, Jongro Gu, 15710, South Korea

About this study

EMR review of intravenous propofol used in target controlled infusion method in children under 2 years old.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children under 2 years of age
  • Children who received intravenous propofol for maintenance of anesthesia

Exclusion criteria

  • Children who underwent general anesthesia with inhalational anesthetics

Treatment and study plan

Propofol

Drug

Intravenous administration with dose of 100-200mcg/kg/min

Primary outcomes

  1. Safety: blood pressure

    Time frame: Intraoperative 1 day

    blood pressure

  2. Safety: blood pressure

    Time frame: Intraoperative 7th days

    blood pressure

Secondary outcomes

  1. Bispectral index

    Time frame: Intraoperative

    optimal surgical condition

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

A Retrospective Study on Safety and Efficacy of Propofol in Small Children

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Apr 28, 2017
Registry last updated
Apr 28, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.